AAAAI 2019 Virtual Annual Meeting Logo

2019 ABAI Continuous Assessment Program Literature Review Recordings– January-June Block

Update your knowledge of recent literature in allergy/immunology, and prepare for the ABAI’s Continuous Assessment Program (CAP) with this literature review course. Presenters provide a guided overview of the articles selected by the ABAI for the CAP for the January-June 2019 term. The four presentations cover a range of clinical conditions central to the specialty, including:

Immune Deficiency, Autoimmunity, and Immune-Based Disorders

Mast Cell Disorders, Eosinophilic Disorders, Anaphylaxis, and Drug-Insect-Vaccine Allergy

Food Allergy, Allergic and Immunologic Skin Disorders, and Urticaria-Angioedema

Head and Neck, and Lung

This activity includes recordings of the Literature Review Course offered in February 2019 at the AAAAI Annual Meeting in San Francisco.

Click the Program tab to access the full list of articles, with links. Please note that All CAP articles can also be accessed through the ABAI web portal.


Target Audience

  • Allergist/Immunologists participating in continuous certification with the American Board of Allergy & Immunology
  • Allied health providers working in allergy/immunology settings
  • Allergy/Immunology Fellows-in-Training preparing for initial certification
  • Other healthcare providers with an interest in allergy/immunology

Learning Objectives

Upon completion of this activity, participants should be able to discuss recently published research relevant to the practice of allergy/immunology.

Available credit: 
  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.
Course opens: 
Course expires: 
ABAI CAP Reference List 1st Cycle 2018 (January – June)

All CAP articles are listed, below.
Articles can also be accessed through the ABAI web portal, and via the following PDF document:

PDF icon ABAI 2018 CAP Reference List_1st Cycle January-June_AAAAI_FINAL.pdf

Section A. Hypersensitivity Disorders - (epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis and differential diagnosis, treatment/management)

A1 Head and Neck

A2 Dermatologic

A3 Lung

A4 Food and Drug Allergy/Hypersensitivity Reactions

A5 Anaphylaxis

Section B. Immunological Disorders - (epidemiology, risk factors, pathogenesis, clinical presentation, diagnosis and differential diagnosis, treatment/management) 

B1 Immune Hypersensitivity Disorders

B2 Immunodeficiencies

B3 Eosinophilic and Gastrointestinal Disorders

Planning Committee

David C. Chaplin, MD PhD FAAAAI
University of Alabama, Birmingham, AL
Relevant relationships: None

Leonard Bacharier, MD FAAAAI
Washington University, St. Louis, MO
Relevant relationships: DBV Technologies, Merck, Vectura (consultant); Boerhinger Ingelheim, Novartis, Circassia, GSK, Teva, Regeneron (advisory board); Novartis (speaker)


Carla M. Davis, MD FAAAAI
Baylor College of Medicine, Houston, TX
Relevant relationships: None

John M. Kelso, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None

John Oppenheimer, MD FAAAAI
Pulmonary and Allergy Associates, Denville, NJ
Relevant relationships: None

John M. Routes, MD FAAAAI
Medical College of Wisconsin, Milwaukee, WI
Relevant relationships: None



Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAAAI Privacy Policy
To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at

Release date
Original release date: March 15, 2019. Valid for credit through December 31, 2019.

Activity-related questions should be directed to

Available Credit

  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.


Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.